These findings, which should be further investigated into different aspects of the LFS phenotype and genotype, strongly suggest that SNP-mediated miR-605 deregulation could affect cancer risk in LFS by inducing some changes in the p53/MDM2 levels. The gene discussed is TP53; the disease is cancer.